Abstract
Mutagenesis has been the foundation of genetics in most model organisms, from prokaryotes to the fruit flies. The simplicity of mutagenizing and propagating these creatures is critical for projects designed to isolate mutations affecting most any imaginable biological process. Not only has mutagenesis been exploited for the identification of phenotypic mutants, but also for the derivation of chromosomal aberrations, such as deletions and inversions, that are powerful genetic tools for many sorts of experiments. The laboratory mouse, which serves as the most important and powerful animal model for human genetics and disease, is only recently being widely exploited by classical phenotype-driven mutagenesis. The limitation has been (and still remains) related to the biology and life cycle of the mouse, which renders large-scale mutagenesis projects rather cumbersome and expensive. Is classical chemical mutagenesis really worthwhile, given the powerful germline manipulation technologies available for mic e Are there new technologies that will render classical mutagenesis obsolete In this review, I shall discuss the tools of mutagenesis that are available for mice, and consider emerging and potential future technologies that will ultimately allow us to investigate, in an unprecedented way, the in vivo function of all mammalian genes.
Keywords: Mutagenesis, CDNA, EST Expressed Sequence Tag
Current Genomics
Title: Mutagenesis in Mice Modern Times
Volume: 1 Issue: 3
Author(s): John C. Schimenti
Affiliation:
Keywords: Mutagenesis, CDNA, EST Expressed Sequence Tag
Abstract: Mutagenesis has been the foundation of genetics in most model organisms, from prokaryotes to the fruit flies. The simplicity of mutagenizing and propagating these creatures is critical for projects designed to isolate mutations affecting most any imaginable biological process. Not only has mutagenesis been exploited for the identification of phenotypic mutants, but also for the derivation of chromosomal aberrations, such as deletions and inversions, that are powerful genetic tools for many sorts of experiments. The laboratory mouse, which serves as the most important and powerful animal model for human genetics and disease, is only recently being widely exploited by classical phenotype-driven mutagenesis. The limitation has been (and still remains) related to the biology and life cycle of the mouse, which renders large-scale mutagenesis projects rather cumbersome and expensive. Is classical chemical mutagenesis really worthwhile, given the powerful germline manipulation technologies available for mic e Are there new technologies that will render classical mutagenesis obsolete In this review, I shall discuss the tools of mutagenesis that are available for mice, and consider emerging and potential future technologies that will ultimately allow us to investigate, in an unprecedented way, the in vivo function of all mammalian genes.
Export Options
About this article
Cite this article as:
Schimenti C. John, Mutagenesis in Mice Modern Times, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351409
DOI https://dx.doi.org/10.2174/1389202003351409 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondria in Chronic Liver Disease
Current Drug Targets Aneuploidy-Inducing Mutations in Mitotic Checkpoint Protein hMad1-Carboxi Terminal Domain Analyzed by SAR and Computational Mutagenesis
Current Proteomics Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Current Alzheimer Research Characterization of the Non-Fibrillar α-Synuclein Oligomers
Protein & Peptide Letters Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
Current Gene Therapy Glial Cells – The Key Elements of Alzheimer´s Disease
Current Alzheimer Research Autoimmune Hepatitis: Pathophysiology, Diagnosis and Pharmacological Therapy
Current Immunology Reviews (Discontinued) Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Extracellular Superoxide Dismutase (EC-SOD) Quenches Free Radicals and Attenuates Age-Related Cognitive Decline: Opportunities for Novel Drug Development in Aging
Current Alzheimer Research Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report
Current Drug Safety Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry Cerebral Malaria - A Neurovascular Pathology with Many Riddles Still to be Solved
Current Neurovascular Research Determination of Propranolol and Naproxen in Urine by using Excitation-Emission Matrix Phosphorescence Coupled with Multivariate Calibration Algorithms
Current Pharmaceutical Analysis An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System
Current Drug Metabolism Psychological Perspectives of Inflammatory Bowel Disease Patients Undergoing Surgery: Rightful Concerns and Preconceptions
Current Drug Targets Intracranial Aneurysms in Sickle Cell Disease
Current Neurovascular Research Recent Advances in Colon Drug Delivery Technology
Drug Delivery Letters The Role of Malnutrition in Older Persons with Mobility Limitations
Current Pharmaceutical Design